NanJing Pharmaceutical Co Ltd
SSE:600713
NanJing Pharmaceutical Co Ltd
Pre-Tax Income
NanJing Pharmaceutical Co Ltd
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
NanJing Pharmaceutical Co Ltd
SSE:600713
|
Pre-Tax Income
¥995.2m
|
CAGR 3-Years
12%
|
CAGR 5-Years
14%
|
CAGR 10-Years
23%
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Pre-Tax Income
¥19.5B
|
CAGR 3-Years
8%
|
CAGR 5-Years
10%
|
CAGR 10-Years
15%
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Pre-Tax Income
¥7B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
8%
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Pre-Tax Income
¥2.9B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
9%
|
CAGR 10-Years
17%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Pre-Tax Income
¥3B
|
CAGR 3-Years
14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
18%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Pre-Tax Income
¥3.6B
|
CAGR 3-Years
6%
|
CAGR 5-Years
3%
|
CAGR 10-Years
13%
|
See Also
What is NanJing Pharmaceutical Co Ltd's Pre-Tax Income?
Pre-Tax Income
995.2m
CNY
Based on the financial report for Mar 31, 2024, NanJing Pharmaceutical Co Ltd's Pre-Tax Income amounts to 995.2m CNY.
What is NanJing Pharmaceutical Co Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
23%
Over the last year, the Pre-Tax Income growth was 5%. The average annual Pre-Tax Income growth rates for NanJing Pharmaceutical Co Ltd have been 12% over the past three years , 14% over the past five years , and 23% over the past ten years .